Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Anthem Biosciences Ltd. Share Price
Day's Range
Day's Range
Low
₹875.15
High
₹891.90
Price Summary
| Previous Close | ₹881.55 |
|---|---|
| Day's Range | ₹875.15 - ₹891.90 |
| Open | ₹882.00 |
| 52 Week Range | ₹579.15 - ₹899.90 |
| Volume | 1,21,798 |
| Market Cap | ₹0.05 |
| Previous Close | ₹883.35 |
|---|---|
| Day's Range | ₹875.85 - ₹891.00 |
| Open | ₹889.30 |
| 52 Week Range | ₹579.45 - ₹899.35 |
| Volume | 9,333 |
| Market Cap | ₹0.05 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1,073.71 |
|---|---|
| Market Cap (₹ in Mn) | 0.05 |
| Dividend Yield(%) | 0.23 |
| Price/Earning (TTM) | 85.88 |
| TTM EPS (₹) | 10.22 |
| P/E Ratio | 62.29 |
| Book Value(₹) | 15.81 |
| PAT Margin (%) | 27.11 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 29.62 |
| Trade Value ( ₹ in Lacs) | 82.44 |
|---|---|
| Market Cap (₹ in Mn) | 0.05 |
| Dividend Yield(%) | 0.23 |
| Price/Earning (TTM) | 85.88 |
| TTM EPS (₹) | 10.22 |
| P/E Ratio | 62.29 |
| Book Value(₹) | 15.81 |
| PAT Margin (%) | 27.11 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 29.62 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 5380.11 | 18445.53 |
| Expenses | N/A | N/A |
| PBT | 1989.38 | 6568.68 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1483.4 | 4512.6 |
About Anthem Biosciences Ltd.
| Founded | 2006 |
|---|---|
| Managing Director | Ajay Bhardwaj |
| NSE Symbol | ANTHEM |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,64,271.32 | 1,940.10 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,26,842.90 | 8,428.30 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,85,999.88 | 4,875.50 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,23,151.56 | 8,657.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,20,099.46 | 1,173.00 | 835.50 - 835.50 |
| Cipla Ltd. | 1,18,071.78 | 1,460.90 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,03,549.99 | 2,253.00 | 1,875.00 - 1,875.00 |
| Lenskart Solutions Ltd. | 1,02,019.00 | 598.50 | 0.00 - 0.00 |
| Mankind Pharma Ltd. | 1,00,137.07 | 2,421.60 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,00,073.46 | 1,196.30 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Anthem Biosciences informs about transcript of conference call
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Anthem Biosciences has informed that it enclosed the transcript of the earnings conference call held on July 22, 2026, at 11:30 AM, post announcement of Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026. The said transcript is also available on website of the Company at https://anthembio.com/.
The above information is a part of company’s filings submitted to BSE.
Anthem Biosciences informs about newspaper publication
Shukra Pharmaceut. - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 235.22 | 53.91 | 336.32 | 235.22 | 53.91 | 336.32 | 567.06 | 325.87 | 74.01 |
| Other Income | 5.40 | 11.10 | -51.35 | 5.40 | 11.10 | -51.35 | 45.85 | 42.07 | 8.99 |
| PBIDT | 217.46 | 24.28 | 795.63 | 217.46 | 24.28 | 795.63 | 333.09 | 169.36 | 96.68 |
| Interest | 4.30 | 2.68 | 60.45 | 4.30 | 2.68 | 60.45 | 10.93 | 5.95 | 83.70 |
| PBDT | 213.16 | 21.60 | 886.85 | 213.16 | 21.60 | 886.85 | 322.16 | 163.41 | 97.15 |
| Depreciation | 10.74 | 7.87 | 36.47 | 10.74 | 7.87 | 36.47 | 34.43 | 30.05 | 14.58 |
| PBT | 202.42 | 13.73 | 1374.29 | 202.42 | 13.73 | 1374.29 | 287.73 | 133.36 | 115.75 |
| TAX | 52.12 | 3.44 | 1415.12 | 52.12 | 3.44 | 1415.12 | 67.26 | 37.62 | 78.79 |
| Deferred Tax | 0.44 | -0.62 | -170.97 | 0.44 | -0.62 | -170.97 | -22.19 | 1.38 | -1707.97 |
| PAT | 150.30 | 10.29 | 1360.64 | 150.30 | 10.29 | 1360.64 | 220.47 | 95.74 | 130.28 |
| Equity | 437.88 | 437.88 | 0.00 | 437.88 | 437.88 | 0.00 | 437.88 | 437.88 | 0.00 |
| PBIDTM(%) | 92.45 | 45.04 | 105.27 | 92.45 | 45.04 | 105.27 | 58.74 | 51.97 | 13.02 |
Lenskart Solutions - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 15244.30 | 11675.40 | 30.57 | 15244.30 | 11675.40 | 30.57 | 52478.35 | 40392.43 | 29.92 |
| Other Income | 690.00 | 713.90 | -3.35 | 690.00 | 713.90 | -3.35 | 2020.11 | 1862.83 | 8.44 |
| PBIDT | 3670.80 | 2724.10 | 34.75 | 3670.80 | 2724.10 | 34.75 | 11833.62 | 6403.71 | 84.79 |
| Interest | 407.00 | 282.90 | 43.87 | 407.00 | 282.90 | 43.87 | 1286.74 | 972.44 | 32.32 |
| PBDT | 3263.80 | 2305.30 | 41.58 | 3263.80 | 2305.30 | 41.58 | 10357.77 | 5431.27 | 90.71 |
| Depreciation | 1311.10 | 906.80 | 44.59 | 1311.10 | 906.80 | 44.59 | 4193.66 | 2915.77 | 43.83 |
| PBT | 1952.70 | 1398.50 | 39.63 | 1952.70 | 1398.50 | 39.63 | 6164.11 | 2515.50 | 145.05 |
| TAX | 437.90 | 354.20 | 23.63 | 437.90 | 354.20 | 23.63 | 1405.27 | 634.78 | 121.38 |
| Deferred Tax | -214.80 | -60.10 | 257.40 | -214.80 | -60.10 | 257.40 | -750.81 | -82.51 | 809.96 |
| PAT | 1514.80 | 1044.30 | 45.05 | 1514.80 | 1044.30 | 45.05 | 4758.84 | 1880.72 | 153.03 |
| Equity | 3477.50 | 1543.40 | 125.31 | 3477.50 | 1543.40 | 125.31 | 3472.83 | 1543.37 | 125.02 |
| PBIDTM(%) | 24.08 | 23.33 | 3.21 | 24.08 | 23.33 | 3.21 | 22.55 | 15.85 | 42.23 |
Caplin Point Labs. - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 2029.50 | 1825.70 | 11.16 | 2029.50 | 1825.70 | 11.16 | 7383.30 | 7524.10 | -1.87 |
| Other Income | 627.90 | 320.30 | 96.03 | 627.90 | 320.30 | 96.03 | 1953.70 | 1345.90 | 45.16 |
| PBIDT | 1572.00 | 1186.40 | 32.50 | 1572.00 | 1186.40 | 32.50 | 5331.50 | 4665.60 | 14.27 |
| Interest | 0.50 | 0.40 | 25.00 | 0.50 | 0.40 | 25.00 | 2.00 | 1.20 | 66.67 |
| PBDT | 1571.50 | 1186.00 | 32.50 | 1571.50 | 1186.00 | 32.50 | 5329.50 | 4664.40 | 14.26 |
| Depreciation | 65.60 | 61.40 | 6.84 | 65.60 | 61.40 | 6.84 | 254.30 | 247.70 | 2.66 |
| PBT | 1505.90 | 1124.60 | 33.91 | 1505.90 | 1124.60 | 33.91 | 5075.20 | 4416.70 | 14.91 |
| TAX | 302.10 | 265.70 | 13.70 | 302.10 | 265.70 | 13.70 | 1109.40 | 1021.80 | 8.57 |
| Deferred Tax | 14.50 | -3.40 | -526.47 | 14.50 | -3.40 | -526.47 | 14.50 | -7.20 | -301.39 |
| PAT | 1203.80 | 858.90 | 40.16 | 1203.80 | 858.90 | 40.16 | 3965.80 | 3394.90 | 16.82 |
| Equity | 152.00 | 152.00 | 0.00 | 152.00 | 152.00 | 0.00 | 152.00 | 152.00 | 0.00 |
| PBIDTM(%) | 77.46 | 64.98 | 19.20 | 77.46 | 64.98 | 19.20 | 72.21 | 62.01 | 16.45 |
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Anthem Biosciences Ltd. is ₹881.55 as of 2026-08-13.
The market capitalisation of Anthem Biosciences Ltd. is ₹49,464.41 as of 2026-08-12.
The 1-year return of Anthem Biosciences Ltd. is 138.10% as of 2026-08-13.
The P/E ratio of Anthem Biosciences Ltd. is 62.29 as of 2026-08-13.
The 52-week high and low of Anthem Biosciences Ltd. are ₹899.90 and ₹579.15, respectively, as of 2026-08-13.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
